drugset / Trial / NCT00485862

Combination Therapy in Patients With Depression

NCT00485862

Phase 4 Completed 214 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to compare sertraline and atomoxetine/sertraline combination therapy in patients with persistent depressive symptoms.

Timeline

Start
2003-06
Primary completion
Completion
2005-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Atomoxetine Other / unclassified
Subject Sertraline Small molecule

Indications